The present invention relates to novel 4-pregenen-11β-17-21-triol-3,20-dione derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals, as modulators of glucocorticoid or mineralocorticoid receptors. The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat disorders associated with glucocorticoid or mineralocorticoid receptor modulation.
本发明涉及新型的4-孕烷-11β-17-21-三醇-3,20-二酮衍
生物,制备它们的方法,含有它们的药物组合物以及它们作为药物的用途,作为糖皮质激素或
醛固酮受体调节剂。本发明具体涉及使用这些化合物及其药物组合物治疗与糖皮质激素或
醛固酮受体调节相关的疾病。